Literature DB >> 24660130

Dynamic Interactions Between Cancer Stem Cells And Their Stromal Partners.

Tea Soon Park1, Vera S Donnenberg2, Albert D Donnenberg3, Elias T Zambidis1, Ludovic Zimmerlin1.   

Abstract

The cancer stem cell (CSC) paradigm presumes the existence of self-renewing cancer cells capable of regenerating all tumor compartments and exhibiting stem cell-associated phenotypes. Recent interpretations of the CSC hypothesis envision stemness as a dynamic trait of tumor-initiating cells rather than a defined and unique cell type. Bidirectional crosstalk between the tumor microenvironment and the cancer bulk is well described in the literature and the tumor-associated stroma, vasculature and immune infiltrate have all been implicated as direct contributors to tumor development. These non-neoplastic cell types have also been shown to organize specific niches within the tumor bulk where they can control the intra-tumor CSC content and alter the fate of CSCs and tumor progenitors during tumorigenesis to acquire phenotypic features for invasion, metastasis and dormancy. Despite the complexity of the tumor-stroma interactome, novel therapeutic approaches envision combining tumor-ablative treatment with manipulation of the tumor microenvironment. We will review the currently available literature that provides clues about the complex cellular network that regulate the CSC phenotype and its niches during tumor progression.

Entities:  

Keywords:  Cancer stem cells; mesenchymal stem/stromal cells; tumor microenvironment; tumor progression; tumor-initiating cells

Year:  2014        PMID: 24660130      PMCID: PMC3956651          DOI: 10.1007/s40139-013-0036-5

Source DB:  PubMed          Journal:  Curr Pathobiol Rep        ISSN: 2167-485X


  127 in total

Review 1.  Two anatomically distinct niches regulate stem cell activity.

Authors:  Hideo Ema; Toshio Suda
Journal:  Blood       Date:  2012-07-11       Impact factor: 22.113

2.  Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells.

Authors:  Shin Hamada; Atsushi Masamune; Tetsuya Takikawa; Noriaki Suzuki; Kazuhiro Kikuta; Morihisa Hirota; Hirofumi Hamada; Masayoshi Kobune; Kennichi Satoh; Tooru Shimosegawa
Journal:  Biochem Biophys Res Commun       Date:  2012-04-09       Impact factor: 3.575

Review 3.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

4.  Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions.

Authors:  Lido Calorini; Francesca Bianchini
Journal:  Cell Commun Signal       Date:  2010-09-07       Impact factor: 5.712

5.  Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.

Authors:  Shunsuke Muramatsu; Shinji Tanaka; Kaoru Mogushi; Rama Adikrisna; Arihiro Aihara; Daisuke Ban; Takanori Ochiai; Takumi Irie; Atsushi Kudo; Noriaki Nakamura; Koh Nakayama; Hiroshi Tanaka; Shoji Yamaoka; Shigeki Arii
Journal:  Hepatology       Date:  2013-05-27       Impact factor: 17.425

6.  Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.

Authors:  M Nishi; Y Sakai; H Akutsu; Y Nagashima; G Quinn; S Masui; H Kimura; K Perrem; A Umezawa; N Yamamoto; S W Lee; A Ryo
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

7.  Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells.

Authors:  Gianluca Storci; Sara Bertoni; Sabrina De Carolis; Alessio Papi; Marina Nati; Claudio Ceccarelli; Chiara Pirazzini; Paolo Garagnani; Alberto Ferrarini; Genny Buson; Massimo Delledonne; Michelangelo Fiorentino; Elisa Capizzi; Elisa Gruppioni; Mario Taffurelli; Donatella Santini; Claudio Franceschi; Giuseppe Bandini; Francesca Bonifazi; Massimiliano Bonafé
Journal:  Am J Pathol       Date:  2013-09-12       Impact factor: 4.307

Review 8.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

9.  T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer.

Authors:  Ana Carolina Monteiro; Ana Carolina Leal; Triciana Gonçalves-Silva; Ana Carolina T Mercadante; Fabiola Kestelman; Sacha Braun Chaves; Ricardo Bentes Azevedo; João P Monteiro; Adriana Bonomo
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more
  19 in total

Review 1.  Capturing Human Naïve Pluripotency in the Embryo and in the Dish.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Elias T Zambidis
Journal:  Stem Cells Dev       Date:  2017-06-26       Impact factor: 3.272

2.  Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.

Authors:  Hang Zheng; Heshu Liu; Huayu Li; Weidong Dou; Jingui Wang; Junling Zhang; Tao Liu; Yingchao Wu; Yucun Liu; Xin Wang
Journal:  Stem Cell Res Ther       Date:  2022-06-09       Impact factor: 8.079

Review 3.  Interaction between prostate cancer stem cells and bone microenvironment regulates prostate cancer bone metastasis and treatment resistance.

Authors:  Lu Yao; Xiangyu Zhang
Journal:  J Cancer       Date:  2022-06-13       Impact factor: 4.478

4.  Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers.

Authors:  J-H Kim; A M Frantz; A L Sarver; B H Gorden Klukas; M Lewellen; T D O'Brien; E B Dickerson; J F Modiano
Journal:  Vet Comp Oncol       Date:  2017-11-20       Impact factor: 2.613

5.  Zfra activates memory Hyal-2+ CD3- CD19- spleen cells to block cancer growth, stemness, and metastasis in vivo.

Authors:  Ming-Hui Lee; Wan-Pei Su; Wan-Jen Wang; Sing-Ru Lin; Chen-Yu Lu; Yu-An Chen; Jean-Yun Chang; Shenq-Shyang Huang; Pei-Yi Chou; Siou-Ru Ye; Szu-Jung Chen; Huan He; Ting-Hsiu Liu; Ying-Tsen Chou; Li-Jin Hsu; Feng-Jie Lai; Shean-Jen Chen; Hoong-Chien Lee; David Kakhniashvili; Steven R Goodman; Nan-Shan Chang
Journal:  Oncotarget       Date:  2015-02-28

Review 6.  Pharmacogenetics of cancer therapy: breakthroughs from beyond?

Authors:  Da-Yong Lu; Ting-Ren Lu; Bin Xu; Jian Ding
Journal:  Future Sci OA       Date:  2015-11-01

7.  Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.

Authors:  Margherita Cortini; Annamaria Massa; Sofia Avnet; Gloria Bonuccelli; Nicola Baldini
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

Review 8.  Adult adipose-derived stem cells and breast cancer: a controversial relationship.

Authors:  Alessandra Bielli; Maria Giovanna Scioli; Pietro Gentile; Sara Agostinelli; Chiara Tarquini; Valerio Cervelli; Augusto Orlandi
Journal:  Springerplus       Date:  2014-07-08

9.  Cancer Stem Cells: Plasticity Works against Therapy.

Authors:  T V Vinogradova; I P Chernov; G S Monastyrskaya; L G Kondratyeva; E D Sverdlov
Journal:  Acta Naturae       Date:  2015 Oct-Dec       Impact factor: 1.845

Review 10.  Immunophenotypic features of dedifferentiated skull base chordoma: An insight into the intratumoural heterogeneity.

Authors:  Kelvin Manuel Piña Batista; Kenia Yoelvi Alvarez Reyes; Fátima Pérez Lopez; Andrés Coca Pelaz; Ivan Fernandez Vega; José Luis Llorente Pendás; Antonio Saiz Ayala; Aurora Astudillo; Jorge Andrés Nuñez Rojas; Patricia Barrio Fernandez
Journal:  Contemp Oncol (Pozn)       Date:  2017-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.